• Info
  • Insider Ownership

Insider Trading & Ownership of Terrie Curran

Location
New York, NY
Summary
The estimated net worth of Terrie Curran is at least $2,645,210 dollars as of 16 Jun 2025. Terrie Curran is the President and Chief Executive, Director of Phathom Pharmaceuticals, Inc. and owns shares of Phathom Pharmaceuticals, Inc. (PHAT) stock worth about $2.4M. Terrie Curran is the Director of Arcutis Biotherapeutics, Inc. and owns shares of Arcutis Biotherapeutics, Inc. (ARQT) stock worth about $245.3K.
Signature
/s/ Latha Vairavan, as Attorney-in-Fact for Terrie Curran
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Terrie Curran and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Quick Takeaways

  • Terrie Curran has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $2,645,210.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Phathom Pharmaceuticals, Inc. ($2,399,933).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Terrie Curran

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PHAT Phathom Pharmaceuticals, Inc. President and Chief Executive, Director $2,399,933 27 Feb 2025
ARQT Arcutis Biotherapeutics, Inc. Director $245,277 12 Jun 2025
MYOV Myovant Sciences Ltd. Director 10 Mar 2023

Insider Transactions Reported by Terrie Curran:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.